Disease-Vaccine-Landing-Page/Respiratory-Syncytial-Virus-(RSV)

According to data released December 27, 2024 by the CDC, 7,128 adverse reactions, including 60 deaths and 477 hospitalizations, have been reported to the Vaccine Adverse Events Reporting System (VAERS). ...

On July 17, 2023, the FDA approved the drug nirsevimab under the trade name Beyfortus, a monoclonal antibody, for the prevention of RSV in infants and children up to 24...

In pre-licensing clinical trials, the most frequently reported side effect was pain at the injection site. Within four days of receipt of the vaccine, the most commonly reported systemic adverse...

During clinical trials for ABRYSVO, in persons 60 years of age and older, the most commonly reported adverse events included swelling, pain, and redness at the injection site, fatigue, headache,...

Vaccines & Disease · RSV Selected NVIC Statements & Commentaries Related to Respiratory Syncytial Virus (RSV) or RSV Vaccine 1 min read Report Harassment to NVIC Has your doctor or...

Vaccines & Disease · RSV What questions should I ask my doctor about Respiratory Syncytial Virus (RSV) vaccine? 2 min read NVIC’s If You Vaccinate, Ask 8! webpage downloadable brochure...

Vaccines & Disease · RSV Who should not get Respiratory Syncytial Virus (RSV) Vaccine? 1 min read According to the package inserts for GSK’s AREXVY, Pfizer’s ABRYSVO, and Moderna’s MRESVIA...

Vaccines & Disease · RSV Who is at highest risk for complications from Respiratory Syncytial Virus (RSV) vaccine? 1 min read Based on the available clinical trial data, pregnant women...

Vaccines & Disease · RSV Can Respiratory Syncytial Virus (RSV) vaccine cause injury & death? 1 min read According to the U.S. Centers for Disease Control and Prevention, side effects...

Vaccines & Disease · RSV What is the history of Respiratory Syncytial Virus (RSV) vaccine in America? 1 min read In 1966, the first vaccine for Respiratory Syncytial Virus (RSV),...